Implant-Based Breast Reconstruction vs TRAM Flap Breast Reconstruction: Solving Problems in a More Simple Way
DOI:
https://doi.org/10.6000/1927-7229.2015.04.02.2Keywords:
Breast reconstruction, Breast Cancer, Complications, Flaps.Abstract
Background: The surgical management of breast cancer is clearly evolving towards less invasive procedures. We are turning away from high priced medicine and are turning toward solving problems in more practical, simple and inexpensive ways.
The purpose of this study was to evaluate immediate breast reconstruction with expanders and implants versus pedicled TRAM Flaps in terms of costs, complication rates, revision rates, operating room time, length of hospital stay and number of secondary procedures.
Methods: A review of 152 immediate breast reconstructions over a 10 year period from april 2000 and December 2010 performed at our Institution, reconstructive techniques included TRAM Flaps in 70 patients and tissue expanders followed by implants in 82 patients.
Results: In the TRAM Flap group the mean operative time was 5.1 hours, the mean length of hospital stay was 4.2 days and revision surgeries were performed in 6 patients (8.5%). In the implant based group the mean operative time was 2.6 hours (including the mastectomy), the mean length of hospital stay was 1.9 days and revision surgeries were performed in 6 patients (7.3%).
On the basis of this review of autologous and prosthetic breast reconstruction in a 10 year period with a mean follow up time of 5.1 years for both groups, prosthetic reconstruction was significantly less expensive.
References
Gurunluoglu R, Gurunluoglu A, Williams SA, et al. Current trends in breast reconstruction. Survey of American society of plastic surgeons 2010. Ann Plast Surg 2013; 70: 103-10. http://dx.doi.org/10.1097/SAP.0b013e31822ed5ce
Khoo A, Kroll S, Reece GP, et al. A comparison of resource costs of immediate and delayed reconstruction. Plast Reconstr Surg 1998; 101(4): 964-968. http://dx.doi.org/10.1097/00006534-199804040-00011
Gieni M, Avram R, Dickson T, et al. Quality of life and patient satisfaction in breast cancer patients after immediate breast reconstruction for invasive cancer: A meta analysis. Breast 2014.
Drucker ZM, Robles VC. A 7 year experience with immediate breast reconstruction after skin sparing mastectomy for cancer. Eur J Surg Oncol 2007l 33: 140-146. http://dx.doi.org/10.1016/j.ejso.2006.10.010
Cordeiro PG, Mc Carthy CM. A single surgeon’s 12 year experience with tissue Expander/Implant breast reconstruction: Part II. An analysis of long-term complications, aesthetic outcomes, and patient satisfaction. Plast Reconstr Surg 2006; 118(4): 832-9. http://dx.doi.org/10.1097/01.prs.0000232397.14818.0e
Castello JR, Garro L, Najera A, et al. Immediate breast reconstruction in two stages using anatomical tissue expansión. Scand J Plast Reconstr Surg 2000; 34: 167. http://dx.doi.org/10.1080/02844310050160042
Cordeiro PG. Breast reconstruction after surgery for cancer. N Engl J Med 2008; 359(15): 1590-1601. http://dx.doi.org/10.1056/NEJMct0802899
Kroll SS, Evans GR, Reece GP, et al. Comparison of Resource Cost between Implant-based and TRAM Flap Breast Reconstruction. Plast Reconstr Surg 1996; 97(2): 364-372. http://dx.doi.org/10.1097/00006534-199602000-00014
Malata CM, McIntosh SA, Purushotham AD. Immediate Breast Reconstruction after mastectomy for cancer. Br J Surg 2000; 87: 1455-1472. http://dx.doi.org/10.1046/j.1365-2168.2000.01593.x
Drucker ZM, Bargallo RE, Zamora RR. Radiotherapy and immediate Expander/Implant breast reconstruction: should reconstruction be delayed? The Breast J 2011; 1-6.
Jones G. The pedicled Tram flap in breast reconstruction. Clin Plast Surg 2007; 34: 83-104. http://dx.doi.org/10.1016/j.cps.2006.11.014
Preminger BA, Pusic AL, McCarthy CM, et al. How should quality-of-life data be incorporated into a cost analysis of breast reconstruction? A consideration of implant versus free TRAM Flap procedures. Plast Reconstr Surg 2008; 121(4): 1075-1082. http://dx.doi.org/10.1097/01.prs.0000304246.66477.cd
Spear SL, Mardini S, Ganz JC. Resource cost comparison of implant-based Breast Reconstruction versus TRAM Flap Breast Reconstruction. Plast Reconstr Surg 2003; 112(1): 101-105. http://dx.doi.org/10.1097/01.PRS.0000066007.06371.47
Clough KB, ODonoghue JM, Fitoussi A. Prospective evaluation of late cosmetic results following TRAM Flap reconstruction. Plast Reconstr Surg 2001; 107 (7): 1710-5. http://dx.doi.org/10.1097/00006534-200106000-00011
Pomahac B, Recht A, May JW, et al. New trends in breast cancer management. Is the era of immediate breast reconstruction changing. Ann Surg 2006; 244(2): 282-288. http://dx.doi.org/10.1097/01.sla.0000217626.88430.c3
Downloads
Published
Issue
Section
How to Cite
Similar Articles
- Laurence A. Cole, Hyperglycosylated hCG Drives Malignancy in Most or All Human Cancers: Tying All Research Together , Journal of Analytical Oncology: Vol. 7 No. 1 (2018)
- Paola Castro-Garcia, Carmen Gil-Gas, Paloma Honrubia-Gómez, Carmen Belen Alvarez-Simón, Jesús-José Ferré-Fernández, Francisco Sánchez-Sánchez, Jose Luis Sánchez-Sánchez, Jose Mª Garcia-Bueno, Sebastiá Sabater, Guadalupe Aparicio, Luis Miguel Antón-Aparicio, Carmen Ramírez-Castillejo, C-Terminal-PEDF Reduces IC50 Doses and Chemoresistant Population of CD133 and BCRP1-Positve Cancer Stem Like Cells , Journal of Analytical Oncology: Vol. 2 No. 4 (2013)
- Eelco R.P. Collette, Monique J. Roobol, Prostate Cancer Treatment on the Basis of an Individual Risk Profile; Can we Reduce Overtreatment? , Journal of Analytical Oncology: Vol. 2 No. 1 (2013)
- Tommaso Cai, Gabriella Nesi, Sandra Mazzoli, Francesca Meacci, Galliano Tinacci, Cesare Selli , Riccardo Bartoletti , Inflammation and Urothelial Bladder Cancer: What we Need to Known? (Review) , Journal of Analytical Oncology: Vol. 4 No. 2 (2015)
- Tedros Bezabeh, Omkar B. Ijare, E. Celia Marginean, Garth Nicholas, Proton Magnetic Resonance Spectroscopy of Sputum for the Non-Invasive Diagnosis of Lung Cancer: Preliminary Findings , Journal of Analytical Oncology: Vol. 1 No. 1 (2012)
- Kenneth K. Wu, Tryptophan Metabolism and Cancer Progression , Journal of Analytical Oncology: Vol. 10 (2021)
- Juan Pablo Nicola, Ana María Masini-Repiso, Emerging Therapeutics for Radioiodide-Refractory Thyroid Cancer , Journal of Analytical Oncology: Vol. 5 No. 2 (2016)
- Anshika N. Singh, Anand P. Khandwekar , Neeti Sharma, Cancer Stem-Cell Related miRNAs: Novel Potential Targets for Metastatic Prostate Cancer , Journal of Analytical Oncology: Vol. 4 No. 4 (2015)
- Rehanna Mansor, Amit Bahl, Jeff Holly , Claire M. Perks , The Role of the IGF Axis in Epithelial-to-Mesenchymal Transition during the Progression of Prostate Cancer , Journal of Analytical Oncology: Vol. 4 No. 4 (2015)
- Hiroko Ina, Kenji Ina, Megumi Kabeya, Satoshi Kayukawa, Takashi Yoshida, Masahiko Yoneda, Lentinan, a Shiitake Mushroom ß-Glucan, Downregulates the Enhanced PD-L1 Expression Induced by Platinum Compounds in Gastric Cancer Cells - , Journal of Analytical Oncology: Vol. 9 (2020)
You may also start an advanced similarity search for this article.